Literature DB >> 20142363

In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis.

Martin Guimond1, Aharon G Freud, Hsiaoyin C Mao, Jianhua Yu, Bradley W Blaser, Jeffrey W Leong, Jeffrey B Vandeusen, Adrienne Dorrance, Jianying Zhang, Crystal L Mackall, Michael A Caligiuri.   

Abstract

IL-15 is required for NK cell development and homeostasis in vivo. Because IL-15 is presented in trans via its high-affinity IL-15Ralpha-chain to cells expressing the IL-15Rbetagamma complex, we postulated that certain IL-15-bearing cells must be required for NK cell homeostasis. Using IL-15(WT/WT) and IL-15(-/-) mice, bone marrow chimeras with normal cellularity, and a selective depletion of CD11c(hi) dendritic cells (DCs), we demonstrate that ablation of the resting CD11c(hi) DC population results in a highly significant decrease in the absolute number of mature NK cells. In contrast, administration of Flt3 ligand increases the CD11c(hi) DC population, which, when expressing IL-15, significantly expands mature NK cells via enhanced survival and proliferation. In summary, a CD11c(hi) DC population expressing IL-15 is required to maintain NK cell homeostasis under conditions of normal cellularity and also is required to mediate Flt3 ligand-induced NK cell expansion in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20142363      PMCID: PMC2924750          DOI: 10.4049/jimmunol.0900685

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha.

Authors:  Fabienne Brilot; Till Strowig; Susanne M Roberts; Frida Arrey; Christian Münz
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

2.  Plasmacytoid dendritic cell reconstitution following bone marrow transplantation: subnormal recovery and functional deficit of IFN-alpha/beta production in response to herpes simplex virus.

Authors:  Sebastien Giraud; Nathalie Dhedin; Hélène Gary-Gouy; Pierre Lebon; Jean-Paul Vernant; Ali Dalloul
Journal:  J Interferon Cytokine Res       Date:  2005-03       Impact factor: 2.607

3.  Requirement for membrane lymphotoxin in natural killer cell development.

Authors:  K Iizuka; D D Chaplin; Y Wang; Q Wu; L E Pegg; W M Yokoyama; Y X Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

4.  Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells.

Authors:  Michelle M Sandau; Kimberly S Schluns; Leo Lefrancois; Stephen C Jameson
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

5.  A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells.

Authors:  Kristin Hochweller; Jörg Striegler; Günter J Hämmerling; Natalio Garbi
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

6.  Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.

Authors:  Bradley W Blaser; Sameek Roychowdhury; Daniel J Kim; Noah R Schwind; Darshna Bhatt; Weifeng Yuan; Donna F Kusewitt; Amy K Ferketich; Michael A Caligiuri; Martin Guimond
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

7.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

Authors:  Mathias Lucas; William Schachterle; Karin Oberle; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2007-03-29       Impact factor: 31.745

8.  Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo.

Authors:  Toshiaki Ohteki; Hiroyuki Tada; Kazuto Ishida; Taku Sato; Chikako Maki; Taketo Yamada; Junji Hamuro; Shigeo Koyasu
Journal:  J Exp Med       Date:  2006-09-11       Impact factor: 14.307

9.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation.

Authors:  Erwan Mortier; Tammy Woo; Rommel Advincula; Sara Gozalo; Averil Ma
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more
  28 in total

1.  Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells.

Authors:  Céline Eidenschenk; Karine Crozat; Philippe Krebs; Ramon Arens; Daniel Popkin; Carrie N Arnold; Amanda L Blasius; Chris A Benedict; Eva Marie Y Moresco; Yu Xia; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Phenotypic and functional activation of hyporesponsive KIRnegNKG2Aneg human NK-cell precursors requires IL12p70 provided by Poly(I:C)-matured monocyte-derived dendritic cells.

Authors:  Shane A Curran; Emanuela Romano; Michael G Kennedy; Katharine C Hsu; James W Young
Journal:  Cancer Immunol Res       Date:  2014-07-14       Impact factor: 11.151

3.  Membrane-bound IL-15 stimulation on peripheral blood natural kiler progenitors leads to the generation of an adherent subset co-expressing dendritic cells and natural kiler functional markers.

Authors:  Simone Negrini; Massimo Giuliani; Deniz Durali; Salem Chouaib; Bruno Azzarone
Journal:  Haematologica       Date:  2011-01-17       Impact factor: 9.941

4.  Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.

Authors:  Sally A Mujaj; Michelle M Spanevello; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2011-05-22

5.  Kruppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen.

Authors:  Chun Shik Park; Ping-Hsien Lee; Takeshi Yamada; Audrea Burns; Ye Shen; Monica Puppi; H Daniel Lacorazza
Journal:  J Leukoc Biol       Date:  2012-02-17       Impact factor: 4.962

Review 6.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

7.  A functional DC cross talk promotes human ILC homeostasis in humanized mice.

Authors:  Silvia Lopez-Lastra; Guillemette Masse-Ranson; Oriane Fiquet; Sylvie Darche; Nicolas Serafini; Yan Li; Mathilde Dusséaux; Helene Strick-Marchand; James P Di Santo
Journal:  Blood Adv       Date:  2017-04-06

8.  Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.

Authors:  Christopher D Dupont; Gretchen Harms Pritchard; Shinya Hidano; David A Christian; Sagie Wagage; Gaia Muallem; Elia D Tait Wojno; Christopher A Hunter
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

9.  Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.

Authors:  Rossana Trotta; Li Chen; Stefan Costinean; Srirama Josyula; Bethany L Mundy-Bosse; David Ciarlariello; Charlene Mao; Edward L Briercheck; Kathleen K McConnell; Anjali Mishra; Lianbo Yu; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

10.  FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.

Authors:  Shun He; Jianhong Chu; Sumithira Vasu; Youcai Deng; Shunzong Yuan; Jianying Zhang; Zhijin Fan; Craig C Hofmeister; Xiaoming He; Henry C Marsh; Steven M Devine; Jianhua Yu
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.